The global cardiac biomarker diagnostic test kits market is poised for significant growth, with an estimated market size of ...
Caris Life Sciences has obtained an FDA approval for its MI Cancer Seek tumor profiling assay, unlocking its use as a ...
AZoLifeSciences on MSN1d
New Study Compares MALDI-TOF MS Assays for Detecting Carbapenemase ActivityAustrian researchers evaluate MALDI-TOF MS assays for carbapenemase detection, assessing their reliability and practicality ...
The study, which is being conducted under an FDA-approved Investigational Device Exemption application, held by GRAIL, leverages GRAIL's targeted methylation platform to detect ctDNA. With GRAIL's ...
Combined with Zomedica's eACTH assay, equine veterinarians get same day answers for their PPID and EMS patients ANN ARBOR, MI ...
Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...
GlobalData on MSN12d
Caris Life Sciences nabs FDA approval for multicancer companion diagnosticThe company’s MI Cancer Seek is approved as a companion diagnostic for multiple cancer therapies, including MSD’s Keytruda, ...
Neurodegenerative diseases of aging like Parkinson's disease (PD) or Alzheimer's disease (AD) are usually not diagnosed until ...
Roche (RHHBY) announced that it has received CE Mark for its Ventana FOLR1 RxDx Assay. This is the first immunohistochemistry, or IHC, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback